Apart from its regulatory role in the NF-κB pathway, USP47 constitutes an interesting target for gastric cancer chemotherapy, because it promotes gastric carcinoma cell proliferation [19], and its depletion sensitize cancer cells to chemotherapy, probably due to the upregulation of Cdc25a [20]. Here, USP47 is linked to gastric cancer.